Continuous Glucose Monitoring Market Outlook 2028
- The global continuous glucose monitoring market was valued at US$ 992.8 Mn in 2020
- It is estimated to expand at a CAGR of 9.5% from 2021 to 2028
- The global continuous glucose monitoring market is expected to surpass the value of US$ 2 Bn by the end of 2028
Continuous Glucose Monitoring Market: Overview
- Increase in incidence and prevalence rate of diabetes type 1 and type 2 across the globe is anticipated to boost the growth of the global market during the forecast period
- Continuous glucose monitoring systems are real-time glucose sensing and monitoring devices that measure and display glucose levels of a patient at regular intervals. The usage of CGM is substantially increasing over traditional glucose monitoring systems, as these systems are user friendly, provide access to real time values and trend, and provide enhanced accuracy.
- Additionally, it has been observed that continuous glucose monitoring significantly helps in diabetes management, especially in type I diabetics, and helps in reducing long-term complications associated with diabetes. Rise in awareness in developed and developing countries, technological advancements, and increase in number of diabetic patients are key factors expected to fuel the growth of the global market during the forecast period.
Request a sample to get extensive insights into the Continuous Glucose Monitoring Market
Continuous Glucose Monitoring Market: Segmentation
- The global continuous glucose monitoring market has been segmented based on device/brand and country/sub-region
- In terms of device/brand, the global continuous glucose monitoring market has been classified into Guardian Real Time CGM system, Dexcom Seven Plus, Dexcom G4 Platinum, FreeStyle Navigator, MiniMed Paradigm Revel/Veo System, and others
- The Guardian Real Time CGM System segment accounted for major market share in 2020, owing to the presence of large companies, such as Medtronic, providing CGM systems in the market for diabetes management. The systems are widely adopted by the consumers, as these are considered efficient sensors for usage as fitness trackers for diabetes. The Dexcom G4 Platinum CGM System segment is expected to witness the fastest growth during the forecast period.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Continuous Glucose Monitoring Market: Country/Sub-region Segmentation
- In terms of country/sub-region, the global continuous glucose monitoring market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market in 2020, followed by Europe and Asia Pacific. The U.S. accounted for significant market share in 2020 in the region owing to large patient pool, increase in geriatric population, rise in baby boomers, sedentary lifestyles, and undiagnosed diabetic patient population are expected to propel the continuous glucose monitoring market in North America. Approvals of innovative CGM systems by FDA and rise in innovative companies developing CGM systems are likely to augment the market in the region in the near future.
- The market in Asia Pacific is likely to grow at a rapid pace from 2021 to 2028. Rapid rise in diabetic population across the region has increased the demand for effective diabetes management systems. This can be attributed to surge in incidence rate of diabetes, unhealthy life style, technically advanced products, and rise in usage of CGM over traditional glucose monitoring systems.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Continuous Glucose Monitoring Market
Continuous Glucose Monitoring Market: Major Players
- Key players operating in the global continuous glucose monitoring market include
- Abbott
- Bayer AG
- Dexcom, Inc.
- Glysens Incorporated
- Insulet Corporation
- Medtronic
- Nova Biomedical Corporation
- Senseonics Incorporated
- Livongo
- BeatO
- Jana Care
- iXensor
- DiaMonTech AG
- These players focus on adopting various strategies to strengthen market presence, expanding product offerings, and strengthening geographic presence. Launch of innovative product offerings, mergers & acquisitions, faster approval of CGM devices, and delivering & creating awareness about continuous glucose monitoring systems are projected to boost the growth of the global continuous glucose monitoring market during the forecast period. Entry in the domestic market in developing countries and offering product line at low cost is a key strategy adopted by the major players to expand in emerging markets.
Continuous Glucose Monitoring Market Snapshot
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 992.8 Mn |
|
Market Forecast Value in 2028 |
US$ 2,065.5 Mn |
|
Growth Rate (CAGR) |
9.5% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value & ‘000 Units for Volume |
|
Market Analysis |
The report includes cross segment analysis at global as well as regional level. Qualitative analysis includes drivers, restraints, opportunities, key trends, etc. The report includes value of various continuous glucose monitoring devices across regional and global level. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Continuous Glucose Monitoring Market – Segmentation
| Device/Brand |
|
| Region |
|
Frequently Asked Questions
What is the total market worth of continuous glucose monitoring market?
Continuous glucose monitoring market is expected to surpass the value of US$ 2 Bn by the end of 2028
What is the anticipated CAGR of the continuous glucose monitoring market in the forecast period?
Continuous glucose monitoring market is estimated to expand at a CAGR of 9.5% from 2021 to 2028
What are the key driving factors for the growth of the continuous glucose monitoring market?
Continuous glucose monitoring market is driven by increase in incidence and prevalence rate of diabetes type 1 and type 2 across the globe.
Which region is expected to project the highest market share in the global continuous glucose monitoring market?
North America accounted for a major share of the global continuous glucose monitoring market
Who are the key players in the global continuous glucose monitoring market?
Key players operating in the global continuous glucose monitoring market includes Abbott, Bayer AG, Dexcom, Inc., Glysens Incorporated, Insulet Corporation, Medtronic, Nova Biomedical Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Continuous Glucose Monitoring Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Continuous Glucose Monitoring Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Prevalence & Incidence rate of Diabetes across globe
5.3. Pricing Analysis of devices
5.4. Overview of Point-of-care Testing
5.5. COVID-19 pandemic impact on Global Continuous Glucose Monitoring Market
6. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Device/Brand
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028
6.3.1. Guardian Real Time CGM System
6.3.2. FreeStyle Navigator
6.3.3. Dexcom Seven Plus CGM System
6.3.4. Dexcom G4 Platinum
6.3.5. MiniMed Paradigm Revel/Veo Systems
6.3.6. Others
6.4. Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand,2021–2028
7. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Country/Sub-region
7.1. Key Findings
7.2. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Region,2017–2028
8. North America Continuous Glucose Monitoring Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028
8.2.1. Guardian Real Time CGM System
8.2.2. FreeStyle Navigator
8.2.3. Dexcom Seven Plus CGM System
8.2.4. Dexcom G4 Platinum
8.2.5. MiniMed Paradigm Revel/Veo Systems
8.2.6. Others
8.3. North America Continuous Glucose Monitoring Market Analysis, by Country, 2017–2028
8.3.1. U.S.
8.3.2. Canada
8.4. North America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028
8.4.1. By Device/Brand
8.4.2. By Country/Sub-region
9. Europe Continuous Glucose Monitoring Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028
9.2.1. Guardian Real Time CGM System
9.2.2. FreeStyle Navigator
9.2.3. Dexcom Seven Plus CGM System
9.2.4. Dexcom G4 Platinum
9.2.5. MiniMed Paradigm Revel/Veo Systems
9.2.6. Others
9.3. Europe Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028
9.4.1. By Device/Brand
9.4.2. By Country/Sub-region
10. Asia Pacific Continuous Glucose Monitoring Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028
10.2.1. Guardian Real Time CGM System
10.2.2. FreeStyle Navigator
10.2.3. Dexcom Seven Plus CGM System
10.2.4. Dexcom G4 Platinum
10.2.5. MiniMed Paradigm Revel/Veo Systems
10.3. Asia Pacific Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028
10.4.1. By Device/Brand
10.4.2. By Country/Sub-region
11. Latin America Continuous Glucose Monitoring Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028
11.2.1. Guardian Real Time CGM System
11.2.2. FreeStyle Navigator
11.2.3. Dexcom Seven Plus CGM System
11.2.4. Dexcom G4 Platinum
11.2.5. MiniMed Paradigm Revel/Veo Systems
11.3. Latin America Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028
11.4.1. By Device/Brand
11.4.2. By Country/Sub-region
12. Middle East & Africa Continuous Glucose Monitoring Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028
12.2.1. Guardian Real Time CGM System
12.2.2. FreeStyle Navigator
12.2.3. Dexcom Seven Plus CGM System
12.2.4. Dexcom G4 Platinum
12.2.5. MiniMed Paradigm Revel/Veo Systems
12.3. Middle East & Africa Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028
12.4.1. By Device/Brand
12.4.2. By Country/Sub-region
13. Competitive Landscape
13.1. Company Profiles (2020)
13.1.1. Abbott
13.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.1.2. Product Portfolio
13.1.1.3. Financial Overview
13.1.1.4. Strategic Overview
13.1.1.5. SWOT Analysis
13.1.2. Bayer AG
13.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.2.2. Product Portfolio
13.1.2.3. Financial Overview
13.1.2.4. Strategic Overview
13.1.2.5. SWOT Analysis
13.1.3. Dexcom, Inc.
13.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.3.2. Product Portfolio
13.1.3.3. Financial Overview
13.1.3.4. Strategic Overview
13.1.3.5. SWOT Analysis
13.1.4. Glysens Incorporated
13.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.4.2. Product Portfolio
13.1.4.3. Strategic Overview
13.1.4.4. SWOT Analysis
13.1.5. Insulet Corporation
13.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.5.2. Product Portfolio
13.1.5.3. Financial Overview
13.1.5.4. Strategic Overview
13.1.5.5. SWOT Analysis
13.1.6. Medtronic
13.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.6.2. Product Portfolio
13.1.6.3. Financial Overview
13.1.6.4. Strategic Overview
13.1.6.5. SWOT Analysis
13.1.7. Nova Biomedical Corporation
13.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.7.2. Product Portfolio
13.1.7.3. Financial Overview
13.1.7.4. Strategic Overview
13.1.7.5. SWOT Analysis
13.1.8. Senseonics Incorporated
13.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.8.2. Product Portfolio
13.1.8.3. Strategic Overview
13.1.8.4. SWOT Analysis
13.1.9. Livongo
13.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.9.2. Product Portfolio
13.1.9.3. Strategic Overview
13.1.9.4. SWOT Analysis
13.1.10. BeatO
13.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.10.2. Product Portfolio
13.1.10.3. Strategic Overview
13.1.10.4. SWOT Analysis
13.1.11. Jana Care
13.1.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.11.2. Product Portfolio
13.1.11.3. Strategic Overview
13.1.11.4. SWOT Analysis
13.1.12. iXensor
13.1.12.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.12.2. Product Portfolio
13.1.12.3. Strategic Overview
13.1.12.4. SWOT Analysis
13.1.13. DiaMonTech AG
13.1.13.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.13.2. Product Portfolio
13.1.13.3. Financial Overview
13.1.13.4. Strategic Overview
13.1.13.5. SWOT Analysis
List of Tables
Table 01: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028
Table 02: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028
Table 03: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028
Table 04: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028
Table 05: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017‒2028
Table 06: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017‒2028
Table 07: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028
Table 08: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by End-user, 2017–2028
Table 09: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Region, 2017–2028
Table 10: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028
Table 11: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028
Table 12: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028
Table 13: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028
Table 14: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028
Table 15: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028
Table 16: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028
Table 17: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028
Table 18: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 19: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028
Table 20: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028
Table 21: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028
Table 22: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028
Table 23: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028
Table 24: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028
Table 25: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028
Table 26: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028
Table 27: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028
Table 28: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028
Table 29: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028
Table 30: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028
Table 31: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028
Table 32: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028
Table 33: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028
Table 34: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028
Table 35: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028
Table 36: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028
Table 37: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028
Table 38: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028
Table 39: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028
Table 40: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028
Table 41: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028
Table 42: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028
Table 43: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028
Table 44: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028
Table 45: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028
List of Figures
Figure 01: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028
Figure 02: Global Continuous Glucose Monitoring Market Value Share, by Device/Brand, 2020
Figure 03: Global Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028
Figure 04: Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028
Figure 05: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Guardian Real Time CGM System, 2017‒2028
Figure 06: Global Continuous Glucose Monitoring Market Value (US$ Mn), by FreeStyle Navigator, 2017‒2028
Figure 07: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Dexcom Seven Plus CGM System, 2017‒2028
Figure 08: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Dexcom G4 Platinum, 2017‒2028
Figure 09: Global Continuous Glucose Monitoring Market Value (US$ Mn), by MiniMed Paradigm Revel/Veo Systems, 2017‒2028
Figure 10: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Others, 2017‒2028
Figure 11: Global Continuous Glucose Monitoring Market Value Share Analysis, by Region, 2020 and 2028
Figure 12: Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Region, 2021–2028
Figure 13: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028
Figure 14: North America Continuous Glucose Monitoring Market Value Share Analysis, by Country, 2020 and 2028
Figure 15: North America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country, 2021–2028
Figure 16: North America Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028
Figure 17: North America Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028
Figure 18: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028
Figure 19: Europe Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub–region, 2020 and 2028
Figure 20: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Sub–region, 2021–2028
Figure 21: Europe Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028
Figure 22: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028
Figure 23: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028
Figure 24: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 25: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028
Figure 26: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028
Figure 27: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028
Figure 28: Latin America Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 29: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028
Figure 30: Latin America Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028
Figure 31: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028
Figure 32: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 33: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028
Figure 34: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028
Figure 35: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028
Figure 36: North America - Company Share Analysis, 2020
Figure 37: Europe - Company Share Analysis, 2020
Figure 38: Asia Pacific - Company Share Analysis, 2020
Figure 39: Latin America - Company Share Analysis, 2020
Figure 40: Middle East & Africa - Company Share Analysis, 2020
